
    
      To determine the feasibility and toxicity of combining epirubicin to fixed does cisplatin; to
      determine the partial and complete response rate and duration of remission; to determine the
      toxicity; to ascertain the potential for greater than 12 month continuous disease-free
      survival and, therefore, potential curability.
    
  